Adhoc: Sandoz Group AG: Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar
Sandoz Group AG / Key word(s): Agreement Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar 09-Sep-2025 / 07:00 CET/CEST Release of a…